Interesting, that is original paper, referenced from article above: http://www.uroweb.org/gls/pdf/09%20Prostate%20Cancer_LRLV2.pdf http://www.uroweb.org/gls/pd

Interesting, that is original paper, referenced from article above: http://www.uroweb.org/gls/pdf/09%20Prostate%20Cancer_LRLV2.pdf http://www.uroweb.org/gls/pdf/09%20Prostate%20Cancer_LRLV2.p... > Tumour grade is clearly significant, with very low survival rates for grade 3 tumours. Although the 10-year cancer-specific rate is equally good (87%) for grade 1 and 2 tumours, the latter have a significantly higher progression rate, with 42% of patients with these tumours developing metastases (Table 8.4). Patients with grade 1, 2 and 3 tumours had 10-year cancer-specific survival rates of 91%, 90% and 74%, respectively, correlating with data from the pooled analysis (49) (LE: 3). Wherever one dies 'with it' or 'because of it', this cancer might progress into metastases, and it brings higher mortality rate.